genprowebdirectory
GEN Edge
Featured News
Multimedia
Subscribe
Login
Contributors
News
Insights
Trends for 2020
Trends for 2021
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
A-Lists
Magazine
Current Issue
Past Issues
Supplements
Subscribe
GEN Protocols
Resources
Summits
Webinars
GEN Live
eBooks/Perspectives
Podcasts
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Best of the Web
Best Apps
Conference Calendar
– INSIDE –
PRECISION MEDICINE
Search
About GEN
Contact GEN
Subscribe/Update Preferences
Log In
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Privacy Policy
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
Subscribe
Login
Contributors
News
Bioprocessing
Lonza Plans New Fill & Finish Facility in Stein, Switzerland
Bioprocessing
Harnessing Bacteria to Make Jet Fuel: Not Just An “Explosive Idea?”
Drug Discovery
Potential Therapeutic Treatment for Androgenetic Alopecia
Dengue
Mosquitoes Find Humans Infected with Zika or Dengue Viruses More Attractive
Infectious Diseases
Enteric Viruses Shown Capable of Spreading via Saliva
Insights
All
Trends for 2020
Trends for 2021
Insights
Single-Cell Functional Proteome Profiling Uncovers Novel Targets for Alzheimer’s Disease
Artificial Intelligence
AI Can Make a Difference on the Factory Floor If Biopharma…
Bioprocessing
Separation Technique Adjusted for mRNA Vaccine Boom
Antibodies
Combatting Therapeutic-Protein Aggregation
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
A-Lists
A-Lists
Top 10 Spatial Biology Companies
A-Lists
Top 25 Biotech Companies of 2022
A-Lists
Seven Biopharma Trends to Watch in 2022
A-Lists
Six of the Best Reports from the Front Line of Biotechnology
A-Lists
Top 10 RNA-Based Biopharmas
Magazine
Current Issue
Past Issues
Supplements
Subscribe
GEN Protocols
Resources
Summits
Webinars
GEN Live
eBooks/Perspectives
Podcasts
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Best of the Web
Best Apps
Conference Calendar
– INSIDE –
PRECISION MEDICINE
Home
RNA
miRNA
miRNA
Antisense
Gene Silencing
lncRNA
miRNA
mRNA
RNAi
shRNA
Most popular
Latest
Featured posts
Most popular
7 days popular
By review score
Random
miRNA
Transgenic Cow Makes Hypoallergenic Milk
miRNA
Protein Designed to Repress Tumor-Promoting miRNA
miRNA
microRNA Gel Helps Damaged Hearts Get to a Better Beat
miRNA
Small-Molecule RNA-Targeting Technology Kills Cancer Cells
miRNA
Testicular Cancer Mapped Genomically and Epigenomically
miRNA
Frank Slack, Ph.D.
miRNA
How miRNA Gets to the Exosomal Loading Dock
miRNA
miRNAs AND CANCER
miRNA
SINGLE miRNA MOLECULE CONTROLS BLOOD VESSEL DEVELOPMENT
miRNA
Servier and miRagen Sign $352M Deal for Cardiovascular miRNA Therapeutics
miRNA
Regulus Therapeutics and Duke Univ. Find that Viral miRNAs Mimic Human...
miRNA
Alzheimer’s Deficits in Neurogenesis and Memory Lessened by Small Molecule
miRNA
Silence and Mirna Partner to Evaluate Delivery Systems for miRNA Therapeutics
miRNA
Anticancer miRNA Coupled to Folate Needs No Protective Packaging
miRNA
Number of microRNAs in Human Genome Skyrockets
1
2
3
...
7
Page 1 of 7
Scroll Up
![Cardiomyocytes (shown in green) proliferating in a mouse heart after gel injection. [University of Pennsylvania]](https://www.genengnews.com/wp-content/uploads/2018/08/Nov30_2017_UnivPenn_cardiomyocytes8911058981-265x198.jpg "microRNA Gel Helps Damaged Hearts Get to a Better Beat")
![RIBOTAC conjugates could offer new approach to destroying toxic gene products and treating genetic diseases. [The Scripps Research Institute]](https://www.genengnews.com/wp-content/uploads/2018/08/May30_2018_TheScrippsResearchInst_MatthewDisneyInLab1948183243-265x198.jpg "Small-Molecule RNA-Targeting Technology Kills Cancer Cells")
![Collaboration gives Servier ex-U.S./Japan global rights to three of Miragen’s preclinical programs.[© Dario Bajurin - Fotolia.com]](https://www.genengnews.com/wp-content/uploads/2018/08/Oct18_2011_3203632_BloodVessels_ServierMiragenCardioDeal1671558221-324x160.jpg "Servier and miRagen Sign $352M Deal for Cardiovascular miRNA Therapeutics")
